Non-hodgkin Lymphoma Genomics - Cancer PHGKB -

Specific PHGKB|Cancer|PHGKB

Non-hodgkin Lymphoma Genomics

- Cancer PHGKB -

What's New

Last Posted: Aug 02, 2018

---

• Tailoring front-line therapy in diffuse large B-cell lymphoma: who should we treat differently?  
  Davies Andrew et al. Hematology. American Society of Hematology. Education Program 2017 2017(1) 284-294
• Cytochrome P450 Genetic Variations Can Predict mRNA Expression, Cyclophosphamide 4-Hydroxylation, and Treatment Outcomes in Chinese Patients With Non-Hodgkin's Lymphoma.  
  Shu Wenying et al. Journal of clinical pharmacology 2017 Jul 57(7) 886-898
• Next-Generation Sequencing in Diffuse Large B-Cell Lymphoma Highlights Molecular Divergence and Therapeutic Opportunities: a LYSA Study.  
  Dubois Sydney et al. Clinical cancer research : an official journal of the American Association for Cancer Research 2016 Jun 22(12) 2919-28
• Precision Medicine for Diffuse Large B-cell Lymphoma.  
  Lim Megan S et al. Clinical cancer research : an official journal of the American Association for Cancer Research 2016 Jun 22(12) 2829-31
• The Promise and Challenges of CAR-T Gene Therapy.  
  Kuehn Bridget M et al. JAMA 2017 Nov
• Serum polychlorinated biphenyls and leukocyte telomere length in a highly-exposed population: The Anniston Community Health Survey.  
  Callahan Catherine L et al. Environment international 2017 Sep 108212-220
• Cancer Risk in Families Fulfilling the Amsterdam Criteria for Lynch Syndrome.  
  Samadder N Jewel et al. JAMA oncology 2017 Aug
• BCL2 mutations do not confer adverse prognosis in follicular lymphoma patients treated with rituximab.  
  Huet Sarah et al. American journal of hematology 2017 Jun 92(6) 515-519
• Clinical utility of recently identified diagnostic, prognostic, and predictive molecular biomarkers in mature B-cell neoplasms.  
  Onaindia Arantza et al. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2017 Jun
• Genetic profiling of MYC and BCL2 in diffuse large B-cell lymphoma determines cell of origin-specific clinical impact.  
  Ennishi Daisuke et al. Blood 2017 Mar